GOLDMAN SACHS GROUP INC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 120 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2015. The put-call ratio across all filers is 3.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$203,000
+91.5%
325,573
+37.2%
0.00%
Q2 2016$106,000
-21.5%
237,364
+84.9%
0.00%
Q1 2016$135,000
-60.4%
128,398
+11.1%
0.00%
Q4 2015$341,000
+196.5%
115,608
+218.3%
0.00%
Q3 2015$115,000
-59.4%
36,322
-23.9%
0.00%
Q2 2015$283,000
+5.2%
47,734
+89.4%
0.00%
Q1 2015$269,000
-34.1%
25,209
-42.0%
0.00%
Q4 2014$408,000
-67.8%
43,482
-73.7%
0.00%
Q3 2014$1,269,000
-74.8%
165,264
-70.6%
0.00%
-100.0%
Q2 2014$5,044,000
+1598.3%
561,708
+913.2%
0.00%
Q1 2014$297,000
+145.5%
55,438
+15.6%
0.00%
Q4 2013$121,00047,9770.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q1 2015
NameSharesValueWeighting ↓
Aisling Capital LLC 2,010,000$905,0000.21%
GLOBEFLEX CAPITAL L P 226,959$102,0000.03%
ACUTA CAPITAL PARTNERS, LLC 62,800$28,0000.01%
MENTA CAPITAL LLC 195,136$87,0000.01%
Orbimed Advisors 1,073,000$481,0000.01%
GOODWIN DANIEL L 22,679$10,0000.00%
TUDOR INVESTMENT CORP ET AL 215,800$97,0000.00%
Renaissance Technologies 2,214,396$992,0000.00%
STOCK YARDS BANK & TRUST CO 30,170$14,0000.00%
HIGHLAND CAPITAL MANAGEMENT, LLC 41,000$18,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders